ArticleGlobal cardiology science & practice2023

Lessons from the first-in-human in vivo CRISPR/Cas9 editing of the TTR gene by NTLA-2001 trial in patients with transthyretin amyloidosis with cardiomyopathy.

Susy KotitPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.